Comparison of the effects of daily and intermittent-dose calcitriol on serum parathyroid hormone and ionized calcium concentrations in normal cats and cats with chronic renal failure

Journal of Veterinary Internal Medicine

Volumn 20, Issue 6, 2006, Pages 1307-1313

  Hostutler, Roger A ^a   DiBartola, Stephen P ^a,c   Chew, Dennis J ^a   Nagode, Larry A ^a   Schenck, Patricia A ^b   Rajala Schultz, Päivi J ^a   Drost, W Tod ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c NONE   (United States)

Author keywords

Kidney; Renal secondary hyperthyroidism; Treatment

Indexed keywords

CALCITRIOL; CALCIUM; CALCIUM CHANNEL STIMULATING AGENT; PARATHYROID HORMONE;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; CAT; CAT DISEASE; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG ADMINISTRATION; FEMALE; HYPERCALCEMIA; MALE; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; SECONDARY HYPERPARATHYROIDISM; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ANIMALS; CALCITRIOL; CALCIUM; CALCIUM CHANNEL AGONISTS; CAT DISEASES; CATS; CROSS-OVER STUDIES; DRUG ADMINISTRATION SCHEDULE; FEMALE; HYPERCALCEMIA; HYPERPARATHYROIDISM, SECONDARY; KIDNEY FAILURE, CHRONIC; MALE; PARATHYROID HORMONE; TREATMENT OUTCOME;

ANIMALIA; FELIDAE;

EID: 33845688639     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1892/0891-6640(2006)20[1307:COTEOD]2.0.CO;2     Document Type: Article

References (30)

1. DiBartola SP, Rutgers HC, Zack PM, et al. Clinicopathologic findings associated with chronic renal disease in cats: 74 cases (1973-1984). J Am Vet Med Assoc 1987;190:1196-1202.
2. Elliott J, Barber PJ. Feline chronic renal failure: Clinical findings in 80 cases diagnosed between 1992 and 1995. J Small Anim Pract 1998;39:78-85.
3. Barber PJ, Elliott J. Feline chronic renal failure: Calcium homeostasis in 80 cases diagnosed between 1992 and 1995. J Small Anim Pract 1998;39:108-116.
4. Slatopolsky E, Caglar S, Pennell JP, et al. On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dog. J Clin Invest 1971;50:492-499.
5. Tanaka Y, Deluca HF. The control of 25-hydroxyvitamin D metabolism by inorganic phosphorus. Arch Biochem Biophys 1973;154:566-574.
6. Portale AA, Booth BE, Halloran BP, et al. Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency. J Clin Invest 1984;73:1580-1589.
7. Brown AJ, Dusso A, Lopez-Hilker S, et al. 1,25-(OH)2D receptors are decreased in parathyroid glands from chronically uremic dogs. Kidney Int 1989;35:19-23.
8. Korkor AB. Reduced binding of [3H]1,25-dihydroxyvitamin D3 in the parathyroid glands of patients with renal failure. N Engl J Med 1987;316:1573-1577.
9. Merke J, Hugel U, Zlotkowski A, et al. Diminished parathyroid 1,25(OH)2D3 receptors in experimental uremia. Kidney Int 1987;32:350-353.
10. Patel SR, Ke HQ, Vanholder R, et al. Inhibition of calcitriol receptor binding to vitamin D response elements by uremic toxins. J Clin Invest 1995;96:50-59.
11. Yalcindag C, Silver J, Naveh-Many T. Mechanism of increased parathyroid hormone mRNA in experimental uremia: Roles of protein RNA binding and RNA degradation. J Am Soc Nephrol 1999;10:2562-2568.
12. Martin KJ, Gonzalez EA, Slatopolsky E. Renal osteodystrophy. In: Brenner BM, Rector FC, eds. Brenner and Rector's The Kidney, 7th ed. St Louis, MO: Elsevier; 2004:2255-2293.
13. Massry SG. Pathogenesis of the anemia of uremia: Role of secondary hyperparathyroidism. Kidney Int Suppl 1983;16:S204-207.
14. Brown SA, Crowell WA, Barsanti JA, et al. Beneficial effects of dietary mineral restriction in dogs with marked reduction of functional renal mass. J Am Soc Nephrol 1991;1:1169-1179.
15. Kaplan MA, Canterbury JM, Bourgoignie JJ, et al. Reversal of hyperparathyroidism in response to dietary phosphorus restriction in the uremic dog. Kidney Int 1979;15:43-48.
16. Barber PJ, Rawlings JM, Markwell PJ, et al. Effect of dietary phosphate restriction on renal secondary hyperparathyroidism in the cat. J Small Anim Pract 1999;40:62-70.
17. Elliott J, Rawlings JM, Markwell PJ, et al. Survival of cats with naturally occurring chronic renal failure: Effect of dietary management. J Small Anim Pract 2000;41:235-242.
18. Ross LA, Finco DR, Crowell WA. Effect of dietary phosphorus restriction on the kidneys of cats with reduced renal mass. Am J Vet Res 1982;43:1023-1026.
19. Slatopolsky E, Weerts C, Thielan J, et al. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients. J Clin Invest 1984;74:2136-2143.
20. Martin KJ, Ballal HS, Domoto DT, et al. Pulse oral calcitriol for the treatment of hyperparathyroidism in patients on continuous ambulatory peritoneal dialysis: Preliminary observations. Am J Kidney Dis 1992;19:540-545.
21. Naveh-Many T, Rahamimov R, Livni N, et al. Parathyroid cell proliferation in normal and chronic renal failure rats: The effects of calcium, phosphate, and vitamin D. J Clin Invest 1995;96:1786-1793.
22. Wang Q, Palnitkar S, Parfitt AM. Parathyroid cell proliferation in the rat: Effect of age and of phosphate administration and recovery. Endocrinology 1996;137:4558-4562.
23. Szotkiewicz M, Zdrojewski Z, Swima-Gillow A, et al. Can hypercalcaemia be avoided during oral calcitriol pulse therapy of secondary hyperparathyroidism in haemodialysis patients? Nephrol Dial Transplant 1995;10:1781-1782.
24. Chew DJ, Nagode LA. Calcitriol in the treatment of chronic renal failure. In: Kirk RW, Bonagura JD, eds. Current Veterinary Therapy XI. Philadelphia, PA: WB Saunders; 1992:857-860.
25. Nagode LA, Chew DJ, Podell M. Benefits of calcitriol therapy and serum phosphorus control in dogs and cats with chronic renal failure: Both are essential to prevent of suppress toxic hyperparathyroidism. Vet Clin North Am Small Anim Pract 1996;26:1293-1330.
26. Torrance AG, Nachreiner R. Human-parathormone assay for use in dogs: Validation, sample handling studies, and parathyroid function testing. Am J Vet Res 1989;50:1123-1127.
27. DeLuca HF. The metabolism, physiology, and function of vitamin D. In: Kumar R, ed. Vitamin D: Basic and Clinical Aspects. Boston, MA: Martinus Nijhoff; 1984:1-68.
28. Dusso AS, Negrea L, Gunawardhana S, et al. On the mechanisms for the selective action of vitamin D analogs. Endocrinology 1991;128:1687-1692.
29. Gerber B, Hassig M, Reusch CE. Serum concentrations of 1,25-dihydroxycholecalciferol and 25-hydroxycholecalciferol in clinically normal dogs and dogs with acute and chronic renal failure. Am J Vet Res 2003;64:1161-1166.
30. Brown SA, Finco DR. Reassessment of the use of calcitriol in chronic renal failure. In: Bonagura JD, ed. Kirk's Current Veterinary Therapy XII. Philadelphia: WB Saunders; 1995:963-966.